Search Results - "Kolaja, KL"

Refine Results
  1. 1

    Opportunities for Use of Human iPS Cells in Predictive Toxicology by Anson, BD, Kolaja, KL, Kamp, TJ

    Published in Clinical pharmacology and therapeutics (01-05-2011)
    “…Toxicity assessment is a major challenge in cost‐effective drug development, and there is a great need for better tools to accurately predict adverse drug…”
    Get full text
    Journal Article
  2. 2
  3. 3
  4. 4

    A Gene Expression Signature that Predicts the Future Onset of Drug-Induced Renal Tubular Toxicity by Fielden, Mark R., Eynon, Barrett P., Natsoulis, Georges, Jarnagin, Kurt, Banas, Deborah, Kolaja, Kyle L.

    Published in Toxicologic pathology (01-10-2005)
    “…One application of genomics in drug safety assessment is the identification of biomarkers to predict compound toxicity before it is detected using traditional…”
    Get full text
    Journal Article
  5. 5

    Investigation of mechanism of drug‐induced cardiac injury and torsades de pointes in cynomolgus monkeys by Misner, DL, Frantz, C, Guo, L, Gralinski, MR, Senese, PB, Ly, J, Albassam, M, Kolaja, KL

    Published in British journal of pharmacology (01-04-2012)
    “…BACKGROUND AND PURPOSE Drug candidates must be thoroughly investigated for their potential cardiac side effects. During the course of routine toxicological…”
    Get full text
    Journal Article
  6. 6

    4-Hydroxynonenal and Malondialdehyde Hepatic Protein Adducts in Rats Treated with Carbon Tetrachloride: Immunochemical Detection and Lobular Localization by Hartley, Dylan P., Kolaja, Kyle L., Reichard, John, Petersen, Dennis R.

    Published in Toxicology and applied pharmacology (15-11-1999)
    “…The metabolism of CCl4 initiates the peroxidation of polyunsaturated fatty acids producing α,β-unsaturated aldehydes, such as 4-hydroxynonenal (4-HNE) and…”
    Get full text
    Journal Article
  7. 7

    Acute Molecular Markers of Rodent Hepatic Carcinogenesis Identified by Transcription Profiling by Kramer, Jeffrey A, Curtiss, Sandra W, Kolaja, Kyle L, Alden, Carl L, Blomme, Eric A. G, Curtiss, William C, Davila, Julio C, Jackson, Carmen J, Bunch, Roderick T

    Published in Chemical research in toxicology (01-04-2004)
    “…Currently, the only way to identify nongenotoxic hepatocarcinogens is through long-term repeat dose studies such as the 2 year rodent carcinogenicity assay…”
    Get full text
    Journal Article
  8. 8

    Transcription Profiling Distinguishes Dose-Dependent Effects in the Livers of Rats Treated with Clofibrate by Kramer, Jeffrey A., Blomme, Eric A.G., Bunch, Roderick T., Davila, Julio C., Jackson, Carmen J., Jones, Patrick F., Kolaja, Kyle L., Curtiss, Sandra W.

    Published in Toxicologic pathology (01-06-2003)
    “…Peroxisome proliferators such as the fibrates act via the peroxisome proliferator activated receptor (PPAR)-α as hypolipidemic agents. Many peroxisome…”
    Get full text
    Journal Article
  9. 9

    Dose-Response Examination of UDP-Glucuronosyltransferase Inducers and Their Ability to Increase both TGF-β Expression and Thyroid Follicular Cell Apoptosis by Kolaja, Kyle L., Klaassen, Curtis D.

    Published in Toxicological sciences (01-11-1998)
    “…Exposure to certain microsomal enzyme inducers that increase UDP-glucuronosyltransferase (UDP-GT) activity decreases thyroid hormone levels, which may lead to…”
    Get full text
    Journal Article
  10. 10
  11. 11

    Dose dependence of phenobarbital promotion of preneoplastic hepatic lesions in F344 rats and B6C3F1 mice: effects on DNA synthesis and apoptosis by Kolaja, K L, Stevenson, D E, Walborg, Jr, E F, Klaunig, J E

    Published in Carcinogenesis (New York) (01-05-1996)
    “…Phenobarbital (PB), a non-genotoxic hepatocarcinogen in rodents, has been studied extensively but its mechanism of carcinogenic action is unclear. PB appears…”
    Get full text
    Journal Article
  12. 12

    Inhibition of gap-junctional-intercellular communication in intact rat liver by nongenotoxic hepatocarcinogens by Kolaja, Kyle L, Engelken, Dustin T, Klaassen, Curtis D

    Published in Toxicology (Amsterdam) (20-04-2000)
    “…Many nongenotoxic hepatocarcinogens can induce cell proliferation, and inhibit apoptosis and gap-junctional-intercellular communication (GJIC). GJIC, the…”
    Get full text
    Journal Article
  13. 13

    Preclinical drug safety analysis by chemogenomic profiling in the liver by Fielden, Mark R, Pearson, Cecelia, Brennan, Richard, Kolaja, Kyle L

    “…The economic hurdles of drug development and the emergence of genomic technologies such as chemogenomics are combining to shift the existing paradigms in…”
    Get more information
    Journal Article
  14. 14

    Vitamin E modulation of hepatic focal lesion growth in mice by Kolaja, K.L. (Indiana University School of Medicine, Indianapolis, IN.), Klauning, J.E

    Published in Toxicology and applied pharmacology (01-04-1997)
    “…The effect of DL-alpha-tocopherol acetate (vitamin E) on hepatic focal lesion growth in male B6C3F1 mice previously treated with diethylnitrosamine (DEN) was…”
    Get full text
    Journal Article
  15. 15

    Inhibition of tumor promotion and hepatocellular growth by dietary restriction in mice by Kolaja, Kyle L., Bunting, Kyle A., Klaunig, James E.

    Published in Carcinogenesis (New York) (01-08-1996)
    “…The effects of dietary restriction on the growth of hepatic focal lesions in phenobarbital (PB) promoted mice were examined. Dietary restriction which can…”
    Get full text
    Journal Article
  16. 16

    Inhibition of WY-14,643 induced hepatic lesion growth in mice by rotenone by ISENBERG, J. S, KOLAJA, K. L, AYOUBI, S. A, WATKINS, J. B, KLAUNIG, J. E

    Published in Carcinogenesis (New York) (01-08-1997)
    “…The effect of rotenone treatment on [4-chloro-6-(2,3-xylidino)-2-pyrimidinylthio] acetic acid (WY-14,643) hepatic lesion growth in male B6C3F1 mice was…”
    Get full text
    Journal Article
  17. 17

    Inhibition of gap-junctional-intercellular communication in thyroid-follicular cells by propylthiouracil and low iodine diet by Kolaja, Kyle L, Petrick, Jay S, Klaassen, Curtis D

    Published in Toxicology (Amsterdam) (21-02-2000)
    “…Propylthiouracil (PTU) or low-iodine diet (LID) treatment increases thyroid-follicular-cell proliferation, possibly by disrupting the movement of small…”
    Get full text
    Journal Article
  18. 18

    Role of oxidative stress in the mechanism of dieldrin's hepatotoxicity by Bachowski, S, Kolaja, K L, Xu, Y, Ketcham, C A, Stevenson, D E, Walborg, Jr, E F, Klaunig, J E

    Published in Annals of clinical and laboratory science (01-05-1997)
    “…The production of reactive oxygen species (ROS) by toxic chemicals has been implicated in acute and chronic disease states, including cancer. This increase in…”
    Get more information
    Journal Article
  19. 19

    Comparative Effects of Dieldrin on Hepatic Ploidy, Cell Proliferation, and Apoptosis in Rodent Liver by Kamendulis, Lisa M., Kolaja, Kyle L., Stevenson, Donald E., Jr, Earl F. Walborg, Klaunig, James E.

    “…Dieldrin-induced hepatocarcinogenesis, which is seen only in the mouse, apparently occurs through a nongenotoxic mechanism. Previous studies have demonstrated…”
    Get full text
    Journal Article
  20. 20

    Selective dieldrin promotion of hepatic focal lesions in mice by Kolaja, Kyte L., Stevenson, Donald E., walborg, Earl F., Klaunig, James E.

    Published in Carcinogenesis (New York) (01-06-1996)
    “…Chronic exposure to a number of chlorinated pesticides, including dieldrin, results in an increased and/or multiplicityof hepatocellular neoplasia in mice,…”
    Get full text
    Journal Article